Workflow
Wall Street's top 5 stocks with the biggest upside in 2025

Group 1: Market Outlook - Investors are looking to capitalize on potential growth in stocks like Nvidia, Tesla, Super Micro Computer, and various Chinese stocks as 2024 approaches [1] - Despite a generally bullish outlook, concerns about a potential bubble or inflation persist, creating uncertainty for 2025 [1] Group 2: Company-Specific Insights - Moderna (NASDAQ: MRNA) has seen a significant decline of over 60% in 2024, but analysts remain optimistic about its recovery potential, forecasting a 54.73% upside in the next 12 months [22][23] - Royalty Pharma (NASDAQ: RPRX) is expected to experience a 74.40% rally in the next year, with an average price target of $44.00 [24][31] - Novo Nordisk (NYSE: NVO) has a moderate buy rating, with analysts predicting a 69.17% increase in stock price, despite a 14% decline year-to-date [12][20] - Advanced Micro Devices (NASDAQ: AMD) is projected to have a 44.26% upside potential, with an average price target of $182.18 [27][33] - Cellectar Biosciences Inc (NASDAQ: CLRB) stands out with a forecasted 2661.34% rally, indicating a 'moderate buy' consensus rating [9][21]